GeneMatrix Inc (109820) — Financial Flexibility Index
GeneMatrix Inc (109820) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of ₩523.83 Million (operating CF ₩500.19 Million minus capex ₩23.65 Million) represents 0% of total liabilities (₩9.72 Billion). Check GeneMatrix Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GeneMatrix Inc Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for GeneMatrix Inc across 11 annual periods. See 109820 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for GeneMatrix Inc (2014–2024)
Year-by-year free cash flow to debt coverage for GeneMatrix Inc. For the full company profile including market capitalisation, see 109820 market cap.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.02x | ₩-166.46 Million | ₩-200.12 Million | ₩9.23 Billion | ▲ +93.2% |
| 2023 | -0.27x | ₩-2.18 Billion | ₩-2.35 Billion | ₩8.21 Billion | ▼ -141.6% |
| 2022 | -0.11x | ₩-850.50 Million | ₩-1.02 Billion | ₩7.72 Billion | ▼ -121.9% |
| 2021 | 0.50x | ₩3.63 Billion | ₩3.37 Billion | ₩7.21 Billion | ▼ -50.7% |
| 2020 | 1.02x | ₩4.87 Billion | ₩4.51 Billion | ₩4.78 Billion | ▲ +745.8% |
| 2019 | -0.16x | ₩-2.09 Billion | ₩-2.28 Billion | ₩13.21 Billion | ▼ -36.5% |
| 2018 | -0.12x | ₩-2.39 Billion | ₩-2.74 Billion | ₩20.68 Billion | ▲ +51.4% |
| 2017 | -0.24x | ₩-1.59 Billion | ₩-1.77 Billion | ₩6.68 Billion | ▼ -1494.9% |
| 2016 | -0.01x | ₩-102.30 Million | ₩-373.25 Million | ₩6.85 Billion | ▲ +68.7% |
| 2015 | -0.05x | ₩-513.06 Million | ₩-591.96 Million | ₩10.74 Billion | ▲ +77.8% |
| 2014 | -0.22x | ₩-1.11 Billion | ₩-1.38 Billion | ₩5.16 Billion | — |